Synlogic, Inc., (Nasdaq: SYBX), a clinical stage company developing a novel class of Synthetic BioticTM therapeutics, announced positive top-line clinical data from patient cohorts of a randomized, double-blind, placebo-controlled Phase 1/2a study of SYNB1618, which […]
Philosopher Nicolae Morar was perplexed by various metaphors tossed about by scientists studying the human microbiome. Microbiologist Brendan Bohannan was sure that thinking of the human body as an ecosystem correctly framed the research being […]
A multicentre Phase I/II double-blind, placebo-controlled study of MRx-4DP0004 in patients with poorly controlled asthma has now commenced. The study will enrol 90 asthma patients not adequately controlled on their current inhaler maintenance therapy. Patients […]
Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases, today announced that the last patient has completed their final […]
Probiotics and Analytical Implications Probiotic products are booming all over the World, in a diversity of foods from yogurt to kefir, kimchi, kombucha, sauerkraut and enriched products as well as dietary supplements, with a global market […]
Some especially good work was published in the microbiome scientific literature this past month. Several of the papers below constitute important investigations that are likely to shape new areas of study or spur new medical […]
Millions of people take capsules of probiotics with the goal of improving their digestion, but what if those bacteria were also able to detect diseases in the gut and indicate when something is awry? New […]
Scientists are advancing our understanding of how the skin microbiome—the diverse community of bacteria, fungi, and other microbes living on the skin’s surface—is important for skin health. Knowing what shapes the skin microbiome may provide […]
The Microbiome Therapeutics Innovation Group (MTIG) announced today the appointment of a new chairman, Ken Blount, Ph.D., Chief Scientific Officer of Rebiotix, Inc. Dr. Blount replaces Tom DesRosier, Esq., Chief Legal Officer of Seres Therapeutics, […]
A simple saliva swab may provide an accurate way of detecting Parkinson’s disease in its earliest stages, according to a study just published in the journal Plos One. In a paper titled “The oral microbiome […]
